share_log

Piper Sandler Assumes Rigel Pharmaceuticals at Neutral, Announces Price Target of $2

Benzinga ·  Apr 3, 2023 09:24

Piper Sandler analyst Allison Bratzel assumes Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral rating and announces Price Target of $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment